Monograph

H01CC01 - Ganirelix

Propably not porphyrinogenic

PNP

Rationale

Peptide, hormone antagonist interacting with sex hormone production.

Chemical description

GnRH-antagonist (peptide). Used in assisted fertilisation for prevention of a premature LH-increase.

IPNet drug reports

Uneventful use reported in 1 patient with acute porphyria.

Similar drugs

Explore alternative drugs in similar therapeutic classes H01C / H01CC or go back.

Tradenames

This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.

Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.

Show more details and information about the listed tradenames

Fyremadel, 0,25 mg/0,5 ml oplossing voor injectie in voorgevulde spuit · Ganirelix Fagron 0,25 mg/0,5 ml, oplossing voor injectie in een voorgevulde spuit · Ganirelix Gedeon Richter 0,25 mg/0,5 ml oplossing voor injectie in voorgevulde spuit · Ganirelix Theramex 0,25 mg/0,5 ml, oplossing voor injectie in een voorgevulde spuit · Orgalutran, 0,25 mg/0,5 ml oplossing voor injectie

Fyremadel · Fyremadel 0.25 mg/0.5 ml sol. inj. s.c. ser. pr?remplie · Ganirelix · Ganirelix Gedeon Richter 0.25 mg/0.5 ml sol. inj. s.c. ser. pr?remplie · Orgalutran · Orgalutran 0.25 mg/0.5 ml sol. inj. s.c. ser. pr?remplie · Ovamex · Ovamex 0.25 mg/0.5 ml sol. inj. s.c. ser. pr?remplie